Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rice NK: Haplo-HSCT with NK Cells for Neuroblastoma
NCT01156350Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Sep 2011
- Primary completion
- Sep 2013
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Natural Killer Cells in neuroblastoma, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
Natural Killer Cells
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT01156350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156350.